SCHEMBL7089535

SCHEMBL7089535

CC(CNC(=O)c1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1)N(C)C

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 15/20 0.56
KDR P35968 2/20 0.52
SGK1 O00141 2/20 0.49
AKT1 P31749 2/20 0.49
AKT2 P31751 2/20 0.49
AKT3 Q9Y243 2/20 0.49
CHEK2 O96017 1/20 0.49
PRKCG P05129 1/20 0.49
MARK2 Q7KZI7 1/20 0.49
CDK1 P06493 1/20 0.49
CDK2 P24941 1/20 0.49
NPC1 O15118 1/20 0.45
AURKA O14965 1/20 0.44
CSNK2A2 P19784 1/20 0.44
CSNK2B P67870 1/20 0.44
CSNK2A1 P68400 1/20 0.44
HDAC4 P56524 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991537 0.86 CHEK1 (0.57) CHEK1KDRSGK1AKT1AKT2
SCHEMBL7000847 0.85 CHEK1 (0.60) CHEK1KDRSGK1AKT1AKT2
SCHEMBL7696820 0.84 CHEK1 (0.73) CHEK1KDRSGK1AKT1AKT2
SCHEMBL6998055 0.84 CHEK1 (0.60) CHEK1KDRSGK1AKT1AKT2
SCHEMBL6999873 0.83 KDR (0.50) CHEK1KDRSGK1AKT1AKT2
SCHEMBL7094319 0.83 CHEK1 (0.66) CHEK1KDRSGK1AKT1AKT2
SCHEMBL7163756 0.83 CHEK1 (0.53) CHEK1KDRSGK1AKT1AKT2
SCHEMBL7091655 0.83 CHEK1 (0.60) CHEK1KDRSGK1AKT1AKT2
SCHEMBL7000911 0.82 CHEK1 (0.56) CHEK1KDRSGK1AKT1AKT2
SCHEMBL7091164 0.82 CHEK1 (0.50) CHEK1KDRSGK1AKT1AKT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed